Delivery Order SPE2DB22D3016-SPE2DB24FBBG6

Award Date 7/17/24
Potential Completion Date 8/7/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. The contract has a ceiling value of $3,989.67 and an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical drug ORGOVYX 120 MG TABLET UU 30S. The order has a firm fixed price of $15,958.68 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which allows the government to efficiently procure...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 MG TABLET pharmaceutical products. The contract has a ceiling value of $1,329.89 and an ultimate completion date of September 10, 2024. This order is placed under an existing Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which has a maximum value of up to $999,999,999 and runs through December 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of the prescription medication ORGOVYX 120 MG TABLET UU 30S. The contract has a ceiling value of $3,989.67 and an ultimate completion date of August 20, 2024. It is a firm-fixed-price contract, which indicates the price is set and not subject to adjustment. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET UU 30S. The contract has a ceiling value of $2,659.78 and a completion date of September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,385.52 firm fixed-price contract is for the medication ORGOVYX 120 MG TABLET with a completion date of June 6, 2025. The award is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through December 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ORGOVYX 120 MG Tablet, a pharmaceutical product, with a firm fixed price ceiling of $1,329.89 and a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supplies distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ORGOVYX 120 MG TABLET, a prescription medication, at a ceiling value of $1,329.89. The contract has an ultimate completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,329.89 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of ORGOVYX 120 MG TABLET UU 30S pharmaceutical products. The award has an ultimate completion date of August 14, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,329.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBG6
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product ORGOVYX 120 MG TABLET. The award has a ceiling value of $3,989.67 and an ultimate completion date of August 7, 2024. This delivery order is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/16/24, 9:33 AM